Galactagogue Supplement for Treatment of Low Milk Supply for Milk Expression, Breast

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Winthrop University, Rock Hill, SC
Milk Expression, Breast
Galactagogue Supplement for Treatment of Low Milk Supply - DietarySupplement
Eligibility
18 - 65
Female
What conditions do you have?
Select

Study Summary

This study aims to determine whether a 20-day supplement with either Oat Mama Lactation Supplement, moringa, or shatavari has any impact on milk production through an increase in serum prolactin levels when compared to the placebo group. This data will be used to determine if clinical recommendations can be made for the use of the studied supplements in increasing milk supply.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Milk Expression, Breast

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Intervention will last 20 days and 24-hour breast milk expression volume will be measured on day 1, 10, and 20 and used to calculate change in 24-hour breast milk expression volume over the trial period

Day 20
Change in Breast Milk Supply
Day 20
Change in Serum Prolactin

Trial Safety

Safety Progress

1 of 3

Other trials for Milk Expression, Breast

Trial Design

4 Treatment Groups

Shatavari Supplement
1 of 4
Moringa Supplement
1 of 4
Oat Mama Lactation Supplement
1 of 4
Placebo
1 of 4
Experimental Treatment
Non-Treatment Group

120 Total Participants · 4 Treatment Groups

Primary Treatment: Galactagogue Supplement for Treatment of Low Milk Supply · Has Placebo Group · N/A

Shatavari Supplement
DietarySupplement
Experimental Group · 1 Intervention: Galactagogue Supplement for Treatment of Low Milk Supply · Intervention Types: DietarySupplement
Moringa Supplement
DietarySupplement
Experimental Group · 1 Intervention: Galactagogue Supplement for Treatment of Low Milk Supply · Intervention Types: DietarySupplement
Oat Mama Lactation Supplement
DietarySupplement
Experimental Group · 1 Intervention: Galactagogue Supplement for Treatment of Low Milk Supply · Intervention Types: DietarySupplement
Placebo
DietarySupplement
PlaceboComparator Group · 1 Intervention: Galactagogue Supplement for Treatment of Low Milk Supply · Intervention Types: DietarySupplement

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: intervention will last 20 days and 24-hour breast milk expression volume will be measured on day 1, 10, and 20 and used to calculate change in 24-hour breast milk expression volume over the trial period
Closest Location: Winthrop University · Rock Hill, SC
Photo of south carolina 1Photo of south carolina 2Photo of south carolina 3
2014First Recorded Clinical Trial
1 TrialsResearching Milk Expression, Breast
5 CompletedClinical Trials

Who is running the clinical trial?

Winthrop UniversityLead Sponsor
2 Previous Clinical Trials
164 Total Patients Enrolled
Hope K Lima, PhDPrincipal InvestigatorWinthrop University

Eligibility Criteria

Age 18 - 65 · Female Participants · 4 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to consume a randomly assigned galactagogue or placebo supplement.
You are willing to provide a blood sample at each lactation consult (day 1, 10, 20).
You are willing to provide 24-hour expressed milk volume either using pre- and post-feed weights, total pump output, or a combination of both on day 1, 10, and 20.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.